HLA-DPB1 specific T-cell receptors are potent mediators of anti-leukemia reactivity in vitro as well as in a xenograft mouse model

被引：0
|
作者：
Vatter, S. [1 ]
Zwerger, M. [1 ]
Schmid, M. [1 ]
Mirbeth, C. [1 ]
Herr, W. [1 ,2 ]
Thomas, S. [1 ,2 ]
机构：
[1] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 3, Regensburg, Germany
[2] Regensburger Ctr Intervent Immunol, Regensburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V495
引用
收藏
页码：129 / 129
页数：1
相关论文
共 19 条
  • [1] T cells modified with an allo-HLA-DPB1 specific TCR and an enhanced EGFRt safety switch induce potent anti-leukemia reactivity in vitro as well as in a xenograft mouse model
    Klobuch, S.
    Wandel, A.
    Vatter, S.
    Zwerger, M.
    Mirbeth, C.
    Herr, W.
    Thomas, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 16 - 16
  • [2] HLA-DPB1 Specific T-CELL Receptors as a Novel Approach in Allogeneic T-CELL Therapy of Leukemias
    Vatter, S.
    Zwerger, M.
    Mirbeth, C.
    Sieboerger, M.
    Herr, W.
    Thomas, S.
    ANNALS OF HEMATOLOGY, 2017, 96 : S81 - S81
  • [3] HLA-DPB1 specific T-cell receptors as novel approach in adoptive immunotherapy of leukemias
    Vatter, S.
    Zwerger, M.
    Mirbeth, C.
    Sieboerger, M.
    Herr, W.
    Thomas, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 136 - 137
  • [4] Towards the identification of hematopoietic tissue-specific T-cell receptors alloreactive to HLA-DPB1
    Arrieta-Bolanos, Thuja
    Crivello, Pietro
    Pietz, Theresa
    Lindemann, Monika
    Horn, Peter A.
    Falkenburg, J. H. Frederik
    Arrieta-Bolanos, Esteban
    Fleischhauer, Katharina
    HLA, 2022, 99 (05) : 428 - 429
  • [5] Characterization of an HLA-DPB1 specific T-cell receptor for adoptive immunotherapy
    Klobuch, Sebastian
    Neidlinger, Elisabeth
    Mirbeth, Carina
    Herr, Wolfgang
    Thomas, Simone
    BONE MARROW TRANSPLANTATION, 2019, 54 : 39 - 40
  • [6] New HLA-DPB1 T-cell epitope model for mismatched UR-HCT
    Morishima, Satoko
    BLOOD, 2024, 144 (16) : 1659 - 1661
  • [7] HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation
    Herr, W.
    Eichinger, Y.
    Beshay, J.
    Bloetz, A.
    Vatter, S.
    Mirbeth, C.
    Distler, E.
    Hartwig, U. F.
    Thomas, S.
    LEUKEMIA, 2017, 31 (02) : 434 - 445
  • [8] HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation
    W Herr
    Y Eichinger
    J Beshay
    A Bloetz
    S Vatter
    C Mirbeth
    E Distler
    U F Hartwig
    S Thomas
    Leukemia, 2017, 31 : 434 - 445
  • [9] Engineering of Human T-Cells with a Novel Aurora-A Kinase-Specific T-Cell Receptor Gene Transfer Confers Anti-Leukemia Reactivity
    Nagai, Kozo
    Fujiwara, Hiroshi
    Ochi, Toshiki
    An, Jun
    Shirakata, Toshiaki
    Mineno, Junichi
    Kuzushirna, Kiyotaka
    Shiku, Hiroshi
    Melenhorst, J. Joseph
    Gostic, Enima
    Price, David A.
    Yasukawa, Masaki
    BLOOD, 2010, 116 (21) : 1741 - 1741
  • [10] Experimental Data on PIRCHE and T-Cell Reactivity: HLA-DPB1-Derived Peptides Identified by PIRCHE-I Show Binding to HLA-A*02:01 in vitro and T-Cell Activation in vivo
    Peereboom, Emma T. M.
    Maranus, Anna E.
    Timmerman, Laura M.
    Geneugelijk, Kirsten
    Spierings, Eric
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (03) : 131 - 139
12